| A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors BR Lanning, LR Whitby, MM Dix, J Douhan, AM Gilbert, EC Hett, ... Nature chemical biology 10 (9), 760-767, 2014 | 365 | 2014 |
| Delineating the role of cooperativity in the design of potent PROTACs for BTK A Zorba, C Nguyen, Y Xu, J Starr, K Borzilleri, J Smith, H Zhu, KA Farley, ... Proceedings of the National Academy of Sciences 115 (31), E7285-E7292, 2018 | 324 | 2018 |
| Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors ME Flanagan, JA Abramite, DP Anderson, A Aulabaugh, UP Dahal, ... Journal of medicinal chemistry 57 (23), 10072-10079, 2014 | 286 | 2014 |
| Chemical proteomics identifies druggable vulnerabilities in a genetically defined cancer L Bar-Peled, EK Kemper, RM Suciu, EV Vinogradova, KM Backus, ... Cell 171 (3), 696-709. e23, 2017 | 222 | 2017 |
| Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a Highly Potent, Selective, Brain Penetrant … JL Henderson, BL Kormos, MM Hayward, KJ Coffman, J Jasti, ... Journal of medicinal chemistry 58 (1), 419-432, 2015 | 186 | 2015 |
| Total synthesis of altohyrtin A (spongistatin 1): part 1 J Guo, KJ Duffy, KL Stevens, PI Dalko, RM Roth, MM Hayward, Y Kishi Angewandte Chemie International Edition 37 (1‐2), 187-190, 1998 | 186 | 1998 |
| Discovery of a JAK3-selective inhibitor: functional differentiation of JAK3-selective inhibition over pan-JAK or JAK1-selective inhibition JB Telliez, ME Dowty, LU Wang, J Jussif, T Lin, L Li, E Moy, P Balbo, W Li, ... ACS chemical biology 11 (12), 3442-3451, 2016 | 152 | 2016 |
| Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF … A Thorarensen, ME Dowty, ME Banker, B Juba, J Jussif, T Lin, F Vincent, ... Journal of medicinal chemistry 60 (5), 1971-1993, 2017 | 136 | 2017 |
| Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of ((S)-2,2-Difluorocyclopropyl)((1R,5S)-3-(2-((1-methyl-1H-pyrazol-4-yl … A Fensome, CM Ambler, E Arnold, ME Banker, MF Brown, J Chrencik, ... Journal of medicinal chemistry 61 (19), 8597-8612, 2018 | 129 | 2018 |
| A proteome-wide atlas of lysine-reactive chemistry ME Abbasov, ME Kavanagh, TA Ichu, MR Lazear, Y Tao, VM Crowley, ... Nature chemistry 13 (11), 1081-1092, 2021 | 124 | 2021 |
| NAPHTHYL‐AND QUINOLYLLUCIFERIN: GREEN AND RED LIGHT EMITTING FIREFLY LUCIFERIN ANALOGUES BR BRANCHING, MM HAYWARD, S BAMFORD, P M BRENNAN, ... Photochemistry and photobiology 49 (5), 689-695, 1989 | 121 | 1989 |
| Bidirectional binding of the TATA box binding protein to the TATA box JM Cox, MM Hayward, JF Sanchez, LD Gegnas, S Van Der Zee, ... Proceedings of the National Academy of Sciences 94 (25), 13475-13480, 1997 | 99 | 1997 |
| Proteome-wide map of targets of T790M-EGFR-directed covalent inhibitors S Niessen, MM Dix, S Barbas, ZE Potter, S Lu, O Brodsky, S Planken, ... Cell chemical biology 24 (11), 1388-1400. e7, 2017 | 88 | 2017 |
| Discovery of brain-penetrant, irreversible kynurenine aminotransferase II inhibitors for schizophrenia AB Dounay, M Anderson, BM Bechle, BM Campbell, MM Claffey, ... ACS medicinal chemistry letters 3 (3), 187-192, 2012 | 88 | 2012 |
| Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexes J Schiemer, R Horst, Y Meng, JI Montgomery, Y Xu, X Feng, K Borzilleri, ... Nature Chemical Biology 17 (2), 152-160, 2021 | 70 | 2021 |
| Discovery of tyrosine kinase 2 (TYK2) inhibitor (PF-06826647) for the treatment of autoimmune diseases BS Gerstenberger, C Ambler, EP Arnold, ME Banker, MF Brown, JD Clark, ... Journal of Medicinal Chemistry 63 (22), 13561-13577, 2020 | 59 | 2020 |
| Design and Discovery of a Selective Small Molecule κ Opioid Antagonist (2-Methyl-N-((2′-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine, PF … PR Verhoest, A Sawant Basak, V Parikh, M Hayward, GW Kauffman, ... Journal of medicinal chemistry 54 (16), 5868-5877, 2011 | 57 | 2011 |
| Pyrrolo [2, 3-d] pyrimidinyl, pyrrolo [2, 3-b] pyrazinyl and pyrrolo [2, 3-d] pyridinyl acrylamides A Thorarensen, MF Brown, A Casimiro-Garcia, CHE Ye, JW Coe, ... US Patent 9,617,258, 2017 | 51 | 2017 |
| Total synthesis of altohyrtin A (Spongistatin 1): Part 2 MM Hayward, RM Roth, KJ Duffy, PI Dalko, KL Stevens, J Guo, Y Kishi Angewandte Chemie International Edition 37 (1‐2), 190-196, 1998 | 41 | 1998 |
| Identification of phosphorylation consensus sequences and endogenous neuronal substrates of the psychiatric risk kinase TNIK Q Wang, SP Amato, DM Rubitski, MM Hayward, BL Kormos, PR Verhoest, ... Journal of Pharmacology and Experimental Therapeutics 356 (2), 410-423, 2016 | 39 | 2016 |
